An Application of the Patient Rule-Induction Method to Detect Clinically Meaningful Subgroups from Failed Phase III Clinical Trials
Author:
Open Access
- 28 June 2021
- journal article
- research article
- Published by ClinMed International Library in International Journal of Clinical Biostatistics and Biometrics
- Vol. 7 (1) , 038
Abstract
Phase III superiority clinical trials have negative results (new treatment is not statistically better than standard of care) due to a number of factors, including patient and disease heterogeneity. However, even a treatment regime that fails to show population-level clinical improvement will have a subgroup of patients that attain a measurable clinical benefit.Keywords
This publication has 23 references indexed in Scilit:
- Participation in the SUCCESS-A Trial Improves Intensity and Quality of Care for Patients with Primary Breast CancerGeburtshilfe und Frauenheilkunde, 2013
- Subgroup identification from randomized clinical trial dataStatistics in Medicine, 2011
- Subgroup identification based on differential effect search—A recursive partitioning method for establishing response to treatment in patient subpopulationsStatistics in Medicine, 2011
- Modifications to the Patient Rule‐Induction Method that utilize non‐additive combinations of genetic and environmental effects to define partitions that predict ischemic heart diseaseGenetic Epidemiology, 2008
- Interaction Trees with Censored Survival DataThe International Journal of Biostatistics, 2008
- An application of the patient rule‐induction method for evaluating the contribution of the Apolipoprotein E and Lipoprotein Lipase genes to predicting ischemic heart diseaseGenetic Epidemiology, 2007
- Adaptive Risk Group RefinementBiometrics, 2005
- Statistical Methods for Analyzing Tissue Microarray DataJournal of Biopharmaceutical Statistics, 2004
- A Combinatorial Partitioning Method to Identify Multilocus Genotypic Partitions That Predict Quantitative Trait VariationGenome Research, 2001
- A Trial Comparing Nucleoside Monotherapy with Combination Therapy in HIV-Infected Adults with CD4 Cell Counts from 200 to 500 per Cubic MillimeterNew England Journal of Medicine, 1996